The nuclear receptor REV-ERBα regulates CYP2E1 expression and acetaminophen hepatotoxicity

References

• Barman PK, Mukherjee R, Prusty BK, Suklabaidya S, Senapati S, Ravindran B. 2016. Chitohexaose protects against acetaminophen-induced hepatotoxicity in mice. Cell Death Dis. 7(5):e2224.
   PubMedGoogle Scholar
• Bateman DN, Dear JW, Thanacoody HK, Thomas SH, Eddleston M, Sandilands EA, Coyle J, Cooper JG, Rodriguez A, Butcher I, et al. 2014. Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning: a randomised controlled trial. Lancet. 383(9918):697–704.
   PubMed Web of Science ®Google Scholar
• Bernal W, Wendon J. 2013. Acute liver failure. N Engl J Med. 369(26):2525–2534.
   PubMed Web of Science ®Google Scholar
• Budnitz DS, Lovegrove MC, Crosby AE. 2011. Emergency department visits for overdoses of acetaminophen-containing products. Am J Prev Med. 40(6):585–592.
   PubMed Web of Science ®Google Scholar
• Chen C, Krausz KW, Idle JR, Gonzalez FJ. 2008. Identification of novel toxicity-associated metabolites by metabolomics and mass isotopomer analysis of acetaminophen metabolism in wild-type and Cyp2e1-null mice. J Biol Chem. 283(8):4543–4559.
   PubMed Web of Science ®Google Scholar
• Chen J, Jiang S, Wang J, Renukuntla J, Sirimulla S, Chen J. 2019. A comprehensive review of cytochrome P450 2E1 for xenobiotic metabolism. Drug Metab Rev. 51(2):178–195.
   PubMed Web of Science ®Google Scholar
• Chen M, Chen M, Lu D, Wang Y, Zhang L, Wang Z, Wu B. 2021. Period 2 regulates CYP2B10 expression and activity in mouse liver. Front Pharmacol. 12:764124.
   PubMed Web of Science ®Google Scholar
• Cheung C, Yu AM, Ward JM, Krausz KW, Akiyama TE, Feigenbaum L, Gonzalez FJ. 2005. The cyp2e1-humanized transgenic mouse: role of cyp2e1 in acetaminophen hepatotoxicity. Drug Metab Dispos. 33(3):449–457.
   PubMed Web of Science ®Google Scholar
• Court MH, Duan SX, von Moltke LL, Greenblatt DJ, Patten CJ, Miners JO, Mackenzie PI. 2001. Interindividual variability in acetaminophen glucuronidation by human liver microsomes: identification of relevant acetaminophen UDP-glucuronosyltransferase isoforms. J Pharmacol Exp Ther. 299(3):998–1006.
   PubMed Web of Science ®Google Scholar
• Duez H, van der Veen JN, Duhem C, Pourcet B, Touvier T, Fontaine C, Derudas B, Baugé E, Havinga R, Bloks VW, et al. 2008. Regulation of bile acid synthesis by the nuclear receptor Rev-erbalpha. Gastroenterology. 135(2):689–698.
   PubMed Web of Science ®Google Scholar
• Fisher K, Vuppalanchi R, Saxena R. 2015. Drug-induced liver injury. Arch Pathol Lab Med. 139(7):876–887.
   PubMed Web of Science ®Google Scholar
• Fontaine C, Staels B. 2007. The orphan nuclear receptor Rev-erbalpha: a transcriptional link between circadian rhythmicity and cardiometabolic disease. Curr Opin Lipidol. 18(2):141–146.
   PubMed Web of Science ®Google Scholar
• Ge W, Wang T, Zhao Y, Yang Y, Sun Q, Yang X, Gao Y, Xu X, Zhang J. 2021. Period1 mediates rhythmic metabolism of toxins by interacting with CYP2E1. Cell Death Dis. 12(1):76.
   PubMed Web of Science ®Google Scholar
• Guillaumond F, Dardente H, Giguère V, Cermakian N. 2005. Differential control of Bmal1 circadian transcription by REV-ERB and ROR nuclear receptors. J Biol Rhythms. 20(5):391–403.
   PubMed Web of Science ®Google Scholar
• Guo L, Yu F, Zhang T, Wu B. 2018. The clock protein Bmal1 regulates circadian expression and activity of sulfotransferase 1a1 in mice. Drug Metab Dispos. 46(10):1403–1410.
   PubMed Web of Science ®Google Scholar
• Hamaguchi H, Fujimoto K, Kawamoto T, Noshiro M, Maemura K, Takeda N, Nagai R, Furukawa M, Honma S, Honma K, et al. 2004. Expression of the gene for Dec2, a basic helix-loop-helix transcription factor, is regulated by a molecular clock system. Biochem J. 382(Pt 1):43–50.
   PubMedGoogle Scholar
• Hrycay EG, Bandiera SM. 2009. Expression, function and regulation of mouse cytochrome P450 enzymes: comparison with human P450 enzymes. Curr Drug Metab. 10(10):1151–1183.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Fan X, Wang Y, Tan H, Chen P, Zeng H, Huang M, Bi H. 2015. Hepato-protective effects of six schisandra lignans on acetaminophen-induced liver injury are partially associated with the inhibition of CYP-mediated bioactivation. Chem Biol Interact. 231:83–89.
   PubMed Web of Science ®Google Scholar
• Kojetin D, Wang Y, Kamenecka TM, Burris TP. 2011. Identification of SR8278, a synthetic antagonist of the nuclear heme receptor REV-ERB. ACS Chem Biol. 6(2):131–134.
   PubMed Web of Science ®Google Scholar
• Larson AM, Polson J, Fontana RJ, Davern TJ, Lalani E, Hynan LS, Reisch JS, Schiødt FV, Ostapowicz G, Shakil AO, Acute Liver Failure Study Group, et al. 2005. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology. 42(6):1364–1372.
   PubMed Web of Science ®Google Scholar
• Lee WM. 2017. Acetaminophen (APAP) hepatotoxicity – isn’t it time for APAP to go away? J Hepatol. 67(6):1324–1331.
   PubMed Web of Science ®Google Scholar
• Lin Y, Lin L, Gao L, Wang S, Wu B. 2020. Rev-erbα regulates hepatic ischemia-reperfusion injury in mice. Biochem Biophys Res Commun. 529(4):916–921.
   PubMed Web of Science ®Google Scholar
• Lu Y, Cederbaum AI. 2006. Cisplatin-induced hepatotoxicity is enhanced by elevated expression of cytochrome P450 2E1. Toxicol Sci. 89(2):515–523.
   PubMed Web of Science ®Google Scholar
• Matsunaga N, Ikeda M, Takiguchi T, Koyanagi S, Ohdo S. 2008. The molecular mechanism regulating 24-hour rhythm of CYP2E1 expression in the mouse liver. Hepatology. 48(1):240–251.
   PubMed Web of Science ®Google Scholar
• McDonnell AM, Dang CH. 2013. Basic review of the cytochrome p450 system. J Adv Pract Oncol. 4(4):263–268.
   PubMedGoogle Scholar
• Nelson DR, Zeldin DC, Hoffman SM, Maltais LJ, Wain HM, Nebert DW. 2004. Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations forgenes, pseudogenes and alternative-splice variants. Pharmacogenetics. 14(1):1–18.
   PubMedGoogle Scholar
• Nelson SD, Mitchell JR, Timbrell JA, Snodgrass WR, Corcoran GB. 3rd. 1976. Isoniazid and iproniazid: activation of metabolites to toxic intermediates in man and rat. Science. 193(4256):901–903.
   PubMed Web of Science ®Google Scholar
• Ohno T, Onishi Y, Ishida N. 2007. The negative transcription factor E4BP4 is associated with circadian clock protein PERIOD2. Biochem Biophys Res Commun. 354(4):1010–1015.
   PubMed Web of Science ®Google Scholar
• Ramachandran A, Jaeschke H. 2018. Acetaminophen toxicity: novel insights into mechanisms and future perspectives. Gene Expr. 18(1):19–30.
   PubMedGoogle Scholar
• Wang S, Li F, Lin Y, Wu B. 2020. Targeting REV-ERBα for therapeutic purposes: promises and challenges. Theranostics. 10(9):4168–4182.
   PubMed Web of Science ®Google Scholar
• Wang S, Lin Y, Yuan X, Li F, Guo L, Wu B. 2018. REV-ERBα integrates colon clock with experimental colitis through regulation of NF-κB/NLRP3 axis. Nat Commun. 9(1):4246.
   PubMedGoogle Scholar
• Xu H, Chen M, Yu F, Zhang T, Wu B. 2020. Circadian clock component Rev-erbα regulates diurnal rhythm of UDP-glucuronosyltransferase 1a9 and drug glucuronidation in mice. Drug Metab Dispos. 48(8):681–689.
   PubMed Web of Science ®Google Scholar
• Yin L, Lazar MA. 2005. The orphan nuclear receptor Rev-erbalpha recruits the N-CoR/histone deacetylase 3 corepressor to regulate the circadian Bmal1 gene. Mol Endocrinol. 19(6):1452–1459.
   PubMedGoogle Scholar
• Yin L, Wu N, Curtin JC, Qatanani M, Szwergold NR, Reid RA, Waitt GM, Parks DJ, Pearce KH, Wisely GB, et al. 2007. Rev-erbalpha, a heme sensor that coordinates metabolic and circadian pathways. Science. 318(5857):1786–1789.
   PubMed Web of Science ®Google Scholar
• Yoon E, Babar A, Choudhary M, Kutner M, Pyrsopoulos N. 2016. Acetaminophen-induced hepatotoxicity: a comprehensive update. J Clin Transl Hepatol. 4(2):131–142.
   PubMed Web of Science ®Google Scholar
• Yuan X, Dong D, Li Z, Wu B. 2019. Rev-erbα activation down-regulates hepatic Pck1 enzyme to lower plasma glucose in mice. Pharmacol Res. 141:310–318.
   PubMed Web of Science ®Google Scholar
• Zanger UM, Schwab M. 2013. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther. 138(1):103–141.
   PubMed Web of Science ®Google Scholar
• Zanger UM, Turpeinen M, Klein K, Schwab M. 2008. Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation. Anal Bioanal Chem. 392(6):1093–1108.
   PubMed Web of Science ®Google Scholar
• Zhang T, Guo L, Yu F, Chen M, Wu B. 2019. The nuclear receptor Rev-erbα participates in circadian regulation of Ugt2b enzymes in mice. Biochem Pharmacol. 161:89–97.
   PubMed Web of Science ®Google Scholar
• Zhang T, Yu F, Guo L, Chen M, Yuan X, Wu B. 2018. Small heterodimer partner regulates circadian cytochromes p450 and drug-induced hepatotoxicity. Theranostics. 8(19):5246–5258.
   PubMed Web of Science ®Google Scholar
• Zhang T, Zhao M, Lu D, Wang S, Yu F, Guo L, Wen S, Wu B. 2018. REV-ERBα regulates CYP7A1 through repression of liver receptor homolog-1. Drug Metab Dispos. 46(3):248–258.
   PubMed Web of Science ®Google Scholar
• Zhao H, Tong Y, Lu D, Wu B. 2020. Circadian clock regulates hepatotoxicity of Tripterygium wilfordii through modulation of metabolism. J Pharm Pharmacol. 72(12):1854–1864.
   PubMed Web of Science ®Google Scholar
• Zhao M, Zhao H, Deng J, Guo L, Wu B. 2019. Role of the CLOCK protein in liver detoxification. Br J Pharmacol. 176(24):4639–4652.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Lin Y, Gao L, Yang Z, Wang S, Wu B. 2020. Circadian pharmacological effects of berberine on chronic colitis in mice: role of the clock component Rev-erbα. Biochem Pharmacol. 172:113773.
   PubMed Web of Science ®Google Scholar